Invex Therapeutics (ASX:IXC) Other Current Receivables : A$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Invex Therapeutics Other Current Receivables?

Invex Therapeutics's Other Current Receivables for the quarter that ended in Dec. 2024 was A$0.00 Mil.

Invex Therapeutics's annual Other Current Receivables increased from Jun. 2022 (A$0.15 Mil) to Jun. 2023 (A$0.33 Mil) but then declined from Jun. 2023 (A$0.33 Mil) to Jun. 2024 (A$0.10 Mil).

Invex Therapeutics Other Current Receivables Historical Data

The historical data trend for Invex Therapeutics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invex Therapeutics Other Current Receivables Chart

Invex Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

Other Current Receivables

0.12

0.02

0.15

0.33

0.10

Invex Therapeutics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Current Receivables	Get a 7-Day Free Trial						-	0.33	-	0.10	-

Invex Therapeutics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Invex Therapeutics Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Invex Therapeutics's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Invex Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invex Therapeutics Ltd (ASX:IXC) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

38 Rowland Street, Level 1, Subiaco, WA, AUS, 6008

Website

https://www.invextherapeutics.com

Invex Therapeutics Ltd is a biopharmaceutical company, focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised ICP including TBI, stroke and hydrocephalus. In addition, the Group has generated early-stage data on the use of Exenatide in the treatment of glaucoma, through the lowering of intraocular pressure in the eye. Geographically, it operates only in Australia.